Pharmacokinetic Models for FcRn-Mediated IgG Disposition
Author:
Open Access
- 14 May 2012
- journal article
- review article
- Published by Wiley in Journal of Biomedicine and Biotechnology
- Vol. 2012, 1-13
Abstract
The objectives were to review available PK models for saturable FcRn-mediated IgG disposition, and to explore an alternative semimechanistic model. Most available empirical and mechanistic PK models assumed equal IgG concentrations in plasma and endosome in addition to other model-specific assumptions. These might have led to inappropriate parameter estimates and model interpretations. Some physiologically based PK (PBPK) models included FcRn-mediated IgG recycling. The nature of PBPK models requires borrowing parameter values from literature, and subtle differences in the assumptions may render dramatic changes in parameter estimates related to the IgG recycling kinetics. These models might have been unnecessarily complicated to address FcRn saturation and nonlinear IgG PK especially in the IVIG setting. A simple semimechanistic PK model (cutoff model) was developed that assumed a constant endogenous IgG production rate and a saturable FcRn-binding capacity. The FcRn-binding capacity was defined as MAX, and IgG concentrations exceeding MAX in endosome resulted in lysosomal degradation. The model parameters were estimated using simulated data from previously published models. The cutoff model adequately described the rat and mouse IgG PK data simulated from published models and allowed reasonable estimation of endogenous IgG turnover rates.Keywords
This publication has 35 references indexed in Scilit:
- Pharmacokinetics of Anti-hepcidin Monoclonal Antibody Ab 12B9m and Hepcidin in Cynomolgus MonkeysThe AAPS Journal, 2010
- Physiologically based pharmacokinetic model for T84.66: A monoclonal anti-CEA antibodyJournal of Pharmaceutical Sciences, 2010
- Kinetics of FcRn-mediated recycling of IgG and albumin in human: Pathophysiology and therapeutic implications using a simplified mechanism-based modelClinical Immunology, 2007
- Analysis of a family of antibodies with different half-lives in mice fails to find a correlation between affinity for FcRn and serum half-lifeMolecular Immunology, 2006
- A Predictive Model of Therapeutic Monoclonal Antibody Dynamics and Regulation by the Neonatal Fc Receptor (FcRn)Annals of Biomedical Engineering, 2005
- Mechanisms of Intravenous Immunoglobulin Action in Immune Thrombocytopenic PurpuraHuman Immunology, 2005
- Pharmacokinetic/Pharmacodynamic Modeling of the Effects of Intravenous Immunoglobulin on the Disposition of Antiplatelet Antibodies in a Rat Model of Immune ThrombocytopeniaJournal of Pharmaceutical Sciences, 2003
- Increasing the serum persistence of an IgG fragment by random mutagenesisNature Biotechnology, 1997
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA IN CHILDHOODThe Lancet, 1981
- Behaviour of 14C- and 131I-labelled plasma proteins in the ratThe International Journal of Applied Radiation and Isotopes, 1956